ENDRA Life Sciences (NDRA) Insider Trading & Ownership $8.07 -0.03 (-0.37%) Closing price 04:00 PM EasternExtended Trading$8.12 +0.05 (+0.63%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ENDRA Life Sciences (NASDAQ:NDRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.04%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$2.04KNumber OfInsiders Selling(Last 12 Months)0 Get NDRA Insider Trade Alerts Want to know when executives and insiders are buying or selling ENDRA Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NDRA Insider Buying and Selling by Quarter ENDRA Life Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/27/2024Group Ag UbsMajor ShareholderBuy106$19.25$2,040.50 (Data available from 1/1/2013 forward) NDRA Insider Trading Activity - Frequently Asked Questions Who is on ENDRA Life Sciences' Insider Roster? The list of insiders at ENDRA Life Sciences includes Alexander Y Tokman, Anthony Digiandomenico, Group Ag Ubs, and Michael Milos Thornton. Learn more on insiders at NDRA. What percentage of ENDRA Life Sciences stock is owned by insiders? 0.04% of ENDRA Life Sciences stock is owned by insiders. Learn more on NDRA's insider holdings. Which ENDRA Life Sciences insiders have been buying company stock? The following insider purchased NDRA shares in the last 24 months: Group Ag Ubs ($2,040.50). How much insider buying is happening at ENDRA Life Sciences? Insiders have purchased a total of 106 NDRA shares in the last 24 months for a total of $2,040.50 bought. ENDRA Life Sciences Key ExecutivesMr. Francois Michelon (Age 58)Chairman, President & CEO Compensation: $388.45kMs. Irina Pestrikova (Age 37)Senior Director of Finance & Secretary Compensation: $185kMr. Michael Thornton Ph.D. (Age 56)Chief Technology Officer Compensation: $279.24kDr. Jonathan Behr Ph.D.Co-FounderMr. Steve FreemanHuman Resources Leader More Insider Trading Tools from MarketBeat Related Companies PAVmed Insider Buying Strata Skin Sciences Insider Buying Co-Diagnostics Insider Buying Sintx Technologies Insider Buying Predictive Oncology Insider Buying Tenon Medical Insider Buying Lifeward Insider Buying Innovative Eyewear Insider Buying Star Equity Insider Buying SeaStar Medical Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:NDRA) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredBanks aren’t ready for this altcoin—are you?An investment opportunity you CAN’T miss… This isn't just any crypto coin- It's a groundbreaking opportunit...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.